News & Press Releases
Filter by:
Mintz advised biotechnology company BeiGene, Ltd. on a collaboration with Celgene Corporation to develop and commercialize BeiGene’s investigational anti-programmed cell death protein 1 inhibitor, BGB-A317.
Mintz Member and Chair of the Energy & Sustainability practice Tom Burton led a panel, “Building a Larger Tent to Mobilize Capital & Exert Influence,” at Big Path Capital’s annual Impact Capitalism Summit.
Mintz’s Elissa Flynn-Poppey Joins Senators Warren and Markey’s Advisory Committee on Massachusetts Judicial Nominations
July 18, 2017
Mintz Member Elissa Flynn-Poppey has been appointed to the bipartisan Advisory Committee on Massachusetts Judicial Nominations led by U.S. Senators Elizabeth Warren and Edward J. Markey.
ML Strategies Welcomes Massachusetts Legislator Brian Dempsey as Senior Vice President and Chief Operating Officer
July 13, 2017
Veteran legislator Brian S. Dempsey, Chairman of the Committee on Ways and Means in the Massachusetts House of Representatives, is joining ML Strategies. Mr. Dempsey will serve as Senior Vice President and COO.
Mintz Scores Decisive Win for Straight Path Before U.S. Court of Appeals for the Federal Circuit
June 29, 2017
The U.S. Court of Appeals for the Federal Circuit found decisively in favor of Mint and client Straight Path IP Group, Inc. in a long-fought battle over three of the licensing firm’s patents. The court upheld a prior 2016 decision by the Patent Trial and Appeal Board.
Mintz attorneys have saved sixty-three of sixty-five challenged patent claims across eight patents in a series of sweeping Inter Partes Review victories for their client, Elm 3DS Innovations, LLC, victories that may pave the way to Elm prevailing in other pending invalidity challenges.
